»Profit Hunter by Equitymaster

On This Day - 2 JUNE 2020
5 'Essential' Smallcaps for a Pandemic-Proof Portfolio

Richa Agarwal, Research analyst

The bad news is pouring in.

As if rising Covid-cases was not enough, we have a fresh challenge to deal with.

Barely two weeks after Amphan hit West Bengal creating havoc, we are facing a cyclonic threat on the west coast.

In another development, for the first time in over two decades, Moody's has downgraded India's sovereign rating to the lowest investment grade.

These would not be standalone setbacks. They are likely to bring with them a fresh set of challenges. That too at a time when our systems and resources are already stretched in dealing with the pandemic.

As investors, you must be prepared.

I'm not saying you should be out of the markets. That might give you the comfort of not having to deal with near term volatility.

But over next two or three years, you would see this as the lost opportunity of the decade.

I believe it's time to go defensive. Fortify your portfolio with disaster proof stocks.

{inlineads1}

Most people would consider being defensive as flocking to the perceived safety of large-cap stocks.

I have different views on this.

While there has to be allocation to largecaps in the portfolio, it should purely be from a diversification perspective.

For the same reason, a good portfolio must have a decent allocation to small-cap stocks as well.

You see, despite all the setbacks, the BSE Sensex is still not cheap enough. It is inching above the median price to earnings ratio of 19.7 times.

Below is a table showing Sensex valuations and returns post Virus outbreaks historically.

Since price to earnings ratio for the smallcap index makes little sense, I've used the ratio of smallcap index to Sensex to asses valuations.

This ratio, at 0.34 times, is well below the median ratio of 0.44 times.

In other words, smallcaps seem to be in a sweet spot for a sharp rebound.

SensexSmallcap Index
Virus OutbreakEstimated PeriodReturns During OutbreakP/E (Median
~19.7x)
1 Year Return Post Outbreak (%)Returns During Outbreak (%)Smallcap to Sensex Ratio (Median ~0.44 )1 Year Return Post Outbreak (%)
Avian InfluenzaJan - Aug 2004-12.21850-9.80.37198
EbolaDec 13- Feb 141.617.7394.50.3175.6
ZikaNov 15- Feb 16-1319.524-15.40.4443.4
Covid -19March -May 20320.3NA-1.80.34NA
Data Source: Ace Equity, Equitymaster

Now this does not mean that you should pick any smallcap that seems cheap in the hope of a rebound.

All these unprecedented disasters are likely to leave huge casualties in their wake.

{inlineads2}

So, you need to be highly selective in the smallcap space.

There are two basic filters that smallcaps you choose must clear, over and above the conventional filters.

  1. Which companies are financially fit to sail through the coronavirus crisis?
  2. Which companies will not only survive, but also thrive in a post-pandemic environment?

Over the last few days, my team and I have been busy recommending stocks that are not only resilient to the crisis but are likely to emerge stronger from it. These stocks would be well positioned for a sharp rebound.

The result has been a report on 5 'Essential' Smallcaps to Ride the Covid-19 Rebound.

Please note this is a new premium report for Hidden Treasure subscribers. For others, subscription is required.


  • Of these 5 stocks, the first is a leading FMCG player - a market leader in a very essential food item. The company is has seen a 100% jump in online sales during the lockdown. It's also tying up with food delivery apps like Zomato for wider access of its products. The company is also the world's largest exporter in its niche segment and its flagship brand commands over 70% market share in the gulf markets.
  • The second stock provides crucial services to the financial markets...has been continuously growing its market share even amid the lockdown. It's a great proxy to ride the twin megatrends of financialisation and digitalisation in my view. One-third of its revenues are annuity based.giving it a strong buffer against the current slowdown.
  • The third stock is a critical supplier to the biggest bluechip companies of India. It's the only company globally to make its own robots in this segment, that too at one third of the cost, and dominate its niche segment with 25% market share. With the food segment (one of the most resilient to the Covid crisis) as its fastest growing segment, I believe it is well placed to weather the storm.
  • The fourth stock is a technology company with the DNA to thrive in a world adopting digitisation and artificial intelligence at unprecedented rates. It's also very adaptive to the macro environment. It's already involved in supporting and empowering the healthcare sector to combat the Covid-19 crisis.
  • The fifth stock is in agribusiness. It offers a product that plays a key role in India's food security. With almost 10% market share in its niche, it supplies the most essential ingredient to the most important sector of the economy.

Here's a glimpse of the fundamentals of these stocks.

Return on Equity (%)Return on Capital Employed (%)Operating Profit Margin (%)Net Profit Margin (%)Debt to Equity
Stock A21.522.831.526.90
Stock B20.120.82112.20.3
Stock C17.619.417.67.90.5
Stock D15.220.817.59.50
Stock E14.718.966470
Data Source: Ace Equity, Equitymaster

The market sentiment has brought these stocks in to a very attractive zone from a valuations perspective.

{inlineads3}

The first 50%-100% gains could come fast. In fact, two of these stocks have hit upper circuits in the last few trading sessions.

But we are more interested in the long-term returns. I believe these five stocks have the potential to run up nearly 3x from the current levels in the next four to five years.

Hidden Treasure subscribers can access the report here. Make sure to use your login details while accessing the link.

If this opportunity interests you and you have not subscribed yet, click here.

Covid-19 is an unfortunate episode in the lives of billions. It will remarkably influence the way we live, and businesses are run. For investors who act with discretion, it could be the best year to grab multibagger stocks available at beaten down valuations. A rebound from these levels could be sharp.

I hope you will not waste this crisis!

For more such opportunities, stay tuned...

Warm regards,

Richa Agarwal
Richa Agarwal
Editor, Hidden Treasure
Equitymaster Agora Research Private Limited (Research Analyst)

PS: If you haven't subscribed to Hidden Treasure, you can get access to my new premium report here.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.

Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement

Disclosure & Disclaimer: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. The Author does not hold any shares in the company/ies discussed in this document. Equitymaster may hold shares in the company/ies discussed in this document under any of its other services.

This document is confidential and is supplied to you for information purposes only. It should not (directly or indirectly) be reproduced, further distributed to any person or published, in whole or in part, for any purpose whatsoever, without the consent of Equitymaster.

This document is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity, who is a citizen or resident or located in any locality, state, country or other jurisdiction, where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject Equitymaster or its affiliates to any registration or licensing requirement within such jurisdiction. If this document is sent or has reached any individual in such country, especially, USA, Canada or the European Union countries, the same may be ignored.

This document does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Our research recommendations are general in nature and available electronically to all kind of subscribers irrespective of subscribers' investment objectives and financial situation/risk profile. Before acting on any recommendation in this document, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the securities referred to in this material and the income from them may go down as well as up, and subscribers may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. Information herein is believed to be reliable but Equitymaster and its affiliates do not warrant its completeness or accuracy. The views/opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. This document should not be construed as an offer to sell or solicitation of an offer to buy any security or asset in any jurisdiction. Equitymaster and its affiliates, its directors, analyst and employees will not be responsible for any loss or liability incurred to any person as a consequence of his or any other person on his behalf taking any decisions based on this document.

As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407